The discovery of robust predictors of treatment response could enable the prediction, from the outset, of a persons probable treatment journey, and thereby pave the way for precision medicine through the clinical implementation of combined phenotypic and genotypic prediction models
The therapy is approved by the FDA and produced under strict quality control
As always, individuals are encouraged to consult healthcare professionals before beginning any new supplementation regimen.
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
Did you get a response You can mix as much, (or as little) water as your vial will hold
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
